MedPath

COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF 10% RETINOL PEEL AND 70% GLYCOLIC ACID PEEL IN THE TREATMENT OF ACANTHOSIS NIGRICANS

Phase 3
Conditions
Health Condition 1: L83- Acanthosis nigricans
Registration Number
CTRI/2023/09/057674
Lead Sponsor
CHERUKUPALLI ANANTH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

CLINICALLY DIAGNOSED AND CONSENTING PATIENTS WITH ACANTHOSIS NIGRICANS

Exclusion Criteria

1. Patients with Post inflammatory hyperpigmentation and other facial dermatoses.

2. Pregnant and Lactating women.

3. Patients who are on topicals/systemic retinoids and other de-pigmenting agents.

4. Non-consenting patients.

5. Patients with unrealistic expectations.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To determine the efficacy and safety of 10% Retinol peel in the treatment of Acanthosis Nigricans. <br/ ><br>2. To determine the efficacy and safety of 70% Glycolic acid peel in the treatment of Acanthosis Nigricans. <br/ ><br>3. To compare the efficacy and safety of the following two treatment options.Timepoint: 2.5 MONTHS
Secondary Outcome Measures
NameTimeMethod
1. Acanthosis Nigricans Area and Severity Index (ANASI) <br/ ><br>2. Investigator’s Global Evaluation (IGE) scale. <br/ ><br>3. Participant’s Global Evaluation (PGE) scale. <br/ ><br>4. Cutaneous adverse reactions scale. <br/ ><br>5.Dermatoscopic findings.Timepoint: 2.5 MONTHS
© Copyright 2025. All Rights Reserved by MedPath